PSD2002 Introduction to Psychedelic Therapies
Discover the principles and practices of psychedelic-assisted therapy in the 12-week PSD2002 – Introduction to Psychedelic Therapies course.
Provider
Details
Enrollment
Course Overview
PSD2002 - Introduction to Psychedelic Therapies provides an in-depth exploration of psychedelic-assisted therapy (PAT), integrating psychoactive compounds such as psilocybin and MDMA with psychotherapy. Over 12 weeks, this online undergraduate unit examines the safety, efficacy, and therapeutic potential of PAT for conditions such as depression, PTSD, and substance-use disorders. Guided by experienced practitioners and leading experts, participants will learn about the stages of PAT, screening and safety protocols, and the pharmacological principles underlying these treatments.
Key topics include the mechanisms of altered states of consciousness, ethical considerations, and risk management strategies unique to PAT. Students will also explore therapist competencies, diverse patient care models, and the therapeutic applications of various psychedelic compounds. This foundational unit does not train participants to practise as psychedelic therapists but equips learners with the knowledge to pursue further study in this rapidly growing field.
This course is only available to undergraduate students.
About the Provider
The Clinical Psychedelic Lab, led by Dr. Paul Liknaitzky, conducts robust clinical trials exploring the efficacy and safety of psychedelic-assisted therapies for various mental health conditions within the Australian healthcare context.
View Monash University profileCourse Details
- PriceFree
- FormatLive Classes
- Lifecycle statusActive
- Skillsfundamental principlestherapeutic processesrisk managementsafety protocolsethical practicepharmacological principlestherapist competenciescare models
- Categories
Related Courses
View all coursesAre Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?
By Double Blind
An article examining whether ketamine clinics could serve as a model for future legal psychedelic therapy. It discusses current ketamine clinic practices, emerging regulation questions, and how clinics are preparing for MDMA and psilocybin services.
Certificate in Psychedelic-Assisted Therapies & Research | Ciisciis Logociis Logo
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Certificate in Psychedelic-Assisted Therapies and Research
By Fluence
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.